產(chǎn)品詳情
簡單介紹：
Anti-CLLD8抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-CLLD8抗體用于**組化實驗,WB實驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CLLD8
Cat. Number:
Anti-CLLD8抗體KL-6414R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Histone methyltransferase involved in left-right axis specification in early development and mitosis. Specifically trimethylates 'Lys-9' of histone H3 (H3K9me3). H3K9me3 is a specific tag for epigenetic transcriptional repression Anti-CLLD8抗體that recruits HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Contributes to H3K9me3 in both the interspersed repetitive elements and centromere-associated repeats. Plays a role in chromosome condensation and segregation during mitosis.
Also known as:
Histone-lysine N-methyltransferase SETDB2; C13orf4; Chromosome 13 open reading frame 4; Chronic lymphocytic leukemia deletion region 8; Chronic lymphocytic leukemia deletion region gene 8; Chronic lymphocytic Anti-CLLD8抗體leukemia deletion region gene 8 protein; Clld8; CLLL8; Gm293; H3-K9-HMTase; Histone H3-K9 methyltransferase; KMT1F; Lysine N-methyltransferase 1F; Probable histone-lysine N-methyltransferase H3 lysine-9 specific; SEB2; SET domain bifurcated 2; SET domain protein, bifurcated, 2; SETB2_HUMAN; Setdb2.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Anti-CLLD8抗體Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CLLD8/SETDB2.
●
Predicted Molecular Weight: 79kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in otherAnti-CLLD8抗體 applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in otherAnti-CLLD8抗體 applications.
Optimal working dilutions must be determined by the end user.
kl029Rb51 E選擇素(SELE)多克隆抗體 Polyclonal Antibody to Selectin, Endothelium (SELE)
kl030Bo01 凋亡相關(guān)因子(FAS)多克隆抗體 Polyclonal Antibody to Factor Related Apoptosis (FAS)
kl030Hu01 凋亡相關(guān)因子(FAS)多克隆抗體 Polyclonal Antibody to Factor Related Apoptosis (FAS)
kl030Mu01 凋亡相關(guān)因子(FAS)多克隆抗體 Polyclonal Antibody to Factor Related Apoptosis (FAS)
kl030Po01 凋亡相關(guān)因子(FAS)多克隆抗體 Polyclonal Antibody to Factor Related Apoptosis (FAS)
kl030Ra01 凋亡相關(guān)因子(FAS)多克隆抗體 Polyclonal Antibody to Factor Related Apoptosis (FAS)
kl030Si01 凋亡相關(guān)因子(FAS)多克隆抗體 Polyclonal Antibody to Factor Related Apoptosis (FAS)
kl031Hu01 凋亡相關(guān)因子配體(FASL)多克隆抗體 Polyclonal Antibody to Factor Related Apoptosis Ligand (FASL)
kl031Mu01 凋亡相關(guān)因子配體(FASL)多克隆抗體 Polyclonal Antibody to Factor Related Apoptosis Ligand (FASL)
kl031Po01 凋亡相關(guān)因子配體(FASL)多克隆抗體 Polyclonal Antibody to Factor Related Apoptosis Ligand (FASL)
kl031Ra01 凋亡相關(guān)因子配體(FASL)多克隆抗體 Polyclonal Antibody to Factor Related Apoptosis Ligand (FASL)
kl031Si01 凋亡相關(guān)因子配體(FASL)多克隆抗體 Polyclonal Antibody to Factor Related Apoptosis Ligand (FASL)
kl032Bo01 酸性成纖維細(xì)胞生長因子(FGF1)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 1, Acidic (FGF1)
kl032Cp01 酸性成纖維細(xì)胞生長因子(FGF1)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 1, Acidic (FGF1)
kl032Ga01 酸性成纖維細(xì)胞生長因子(FGF1)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 1, Acidic (FGF1)
kl032Hu01 酸性成纖維細(xì)胞生長因子(FGF1)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 1, Acidic (FGF1)
kl032Mu01 酸性成纖維細(xì)胞生長因子(FGF1)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 1, Acidic (FGF1)
kl032Po01 酸性成纖維細(xì)胞生長因子(FGF1)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 1, Acidic (FGF1)
kl032Ra01 酸性成纖維細(xì)胞生長因子(FGF1)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor 1, Acidic (FGF1)
kl033Bo01 干擾素α(IFNα)多克隆抗體 Polyclonal Antibody to Interferon Alpha (IFNa)
kl033Ca01 干擾素α(IFNα)多克隆抗體 Polyclonal Antibody to Interferon Alpha (IFNa)
